Intracellular Bacteria and Protozoa - Intracellular Delivery: Fundamentals and Applications - page 804

Lim SA 2006 Ethambutol-associated Optic Neuropathy. Ann Acad Med Singapore 35: 274-278
Longmuir KJ, Robertson RT, Haynes SM, Baratta JL, Waring AJ (2006) Effective targeting of
liposomes to liver and hepatocytes in vivo by incorporation of a Plasmodium amino acid
sequence. Pharm Res 23: 759-769
Lortholary O, Tod M, Cohen Y, Petitjean O (1995) Aminoglycosides. Medical Clinics of North
America 79: 761-87
Lyon M, Deakin JA, Gallagher JT (1994) Liver heparin sulfate structure. A novel molecular
design. J Biol Chem 269: 11208-11215
Maertens J, Boogaerts MA (1998) Anti-infective strategies in neutropenic patients. Acta Clinica
Belgica 53: 168-77
Maurin M, Raoult D (1997) Intracellular organisms. Int J Antimicrob Agents 9: 61-70
Magallanes M, Dijkstra J, Fiererl J (1993) Liposome-Incorporated ciprofloxacin in treatment of
murine Salmonellosis. Antimicrob Agents Chemother 37: 2293-2297
Mandawgade SD, Sharma S, Pathak S, Patravale VB (2008) Development of SMEDDS using
natural lipophile: Application to beta-Artemether delivery. Int J Pharm 362: 179-183
McCormick BA (2004) Chapter 1: Invasion mechanisms of Salmonella . In: Lamont RJ (ed)
Advances in molecular and cell microbiology. Bacterial invasion of host cells. Cambridge
University Press, Cambridge
McOrist S (2000) Obligate intracellular bacteria and antibiotic resistance. Trends Microbiol 8:
483
Mehta RT (1996) Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and
improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avi-
um-M. intracellulare complex infection. Antimicrob Agents Chemother 40: 1893-1902
Ménard R (2000) The journey of the malaria sporozoite through its hosts: two parasite proteins
lead the way. Microbes Infect 2: 633-642
Miao L, Stafford A, Nir S, Turco SJ, Flanagan TD, Epand RM (1995) Potent inhibition of viral
fusion by the lipophosphoglycan of Leishmania donovani . Biochemistry 34: 4676 - 4683
Minodier P, Parola P (2007) Cutaneous leishmaniasis treatment. Travel Med Infect Dis 5(3):
150-158
Minodier P, Retornaz K, Horelt A, Garnier JM (2003) Liposomal amphotericin B in the treatment
of visceral leishmaniasis in immunocompetent patients. Fundam Clin Pharmacol 17:
183-188
Misra A, Hickey AJ, Rossi C, Borchard G, Terada H, Makino K, Fourie PB, Colombo P (2010)
Inhaled drug therapy for treatment of tuberculosis. Tuberculosis [Epub ahead of print]
Mitchell DJ, Kim DT, Steinman L, Fathman CG, Rothbard JB (2000) Polyarginine enters cells
more efficiently than other polycationic homopolymers. J Peptide Res 56, 318-325
Mitchison DA (2005) Drug resistance in tuberculosis. Eur Respir J 25: 376-379
Mohammadi G, Valizadeh H, Barzegar-Jalali M, Lotfipour F, Adibkia K, Milani M, Azhdarzadeh
M, Kiafar F, Nokhodchi A (2010) Development of azithromycin-PLGA nanoparticles:
Physicochemical characterization and antibacterial effect against Salmonella typhi . Colloids
Surf B Biointerfaces 80: 34-39
Molina J, Brener Z, Romanha A, Urbina JA (2000) In vivo activity of the bis-triazole D0870
against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma
cruzi. J Antimicrob Chemother 46: 137-140
Molina J, Urbina JA, Gref R, Brener Z, Maciel Rodrigues JJ (2001) Cure of experimental
Chagas's disease by the bis-triazole D0870 incorporated into stealth polyethyleneglycol-
polylactide nanospheres. J Antimicrob Chemother 47: 101-104
Montanari J, Maidana C, Esteva MI, Salomon C, Morilla MJ, Romero EL (2010) Sunlight trig-
gered photodynamic ultradeformable liposomes against Leishmania braziliensis are also
leishmanicidal in the dark. J Control Release 147: 368-376
Morilla MJ, Benavidez P, Lopez MO, Bakas L, Romero EL (2002) Development and in vitro
characterisation of a benznidazole liposomal formulation. Int J Pharm 249: 89-99
Morilla MJ, Montanari J, Frank F, Malchiodi E, Corral R, Petray P, Romero EL (2005) Etanidazole
in pH-sensitive liposomes: design, characterization and in vitro/in vivo anti- Trypanosoma cruzi
activity. J Control Release 103: 599-607